| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |